DIMA Biotechnology LLC is a biotechnology company specializing in membrane protein and monoclonal antibody development. We have built a number of proprietary platforms with a focus on druggable targets.
We offer solutions for full-length multipass transmembrane proteins including Synthetic Nanodisc, PeptiNanodisc, VLP, MNP, Exosome, and Detergent extraction. Most of our proteins are validated by functional assays and SDS-PAGE.
Our proprietary single B cell cloning platform can generate recombinant rabbit monoclonal antibodies (mAb) in one and a half months. Combined with our antibody engineering and functional assay evaluation services, we provide integrated solutions for scientific research, clinical diagnosis, and therapeutic R&D.